Celgene CEO on CNBC: Getting patients access to 'precision' medicines is crucial

by: Robert Goldberg |
08/03/2017

You can watch Celgene's CEO discuss precision medicine and read his op-ed about Celgene's novel and proactive approach to helping patients access it here.

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Celgene CEO on CNBC: Getting patients access to 'precision' medicines is crucial

Latest from CMPI

Coronavirus: America’s drug supply needs a refill

Prescription for Failure: The Ills of Socialized Medicine (CPAC 2020)

How to eliminate surprise medical bills

Keep Canadian drugs out of U.S. medicine cabinets

Blog Roll

Categories